Sec. 2. ADDRESSING PROBLEMS RELATED TO PRENATAL OPIOID USE
275 words·~1 min read·
/statute-compilations/comps-11756/sec-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 2 ADDRESSING PROBLEMS RELATED TO PRENATAL OPIOID USE ###
(a)Review of Programs The Secretary of Health and Human Services (referred to in this Act as the “Secretary”) shall conduct a review of planning and coordination related to prenatal opioid use, including neonatal abstinence syndrome, within the agencies of the Department of Health and Human Services. ###
(b)Strategy In carrying out subsection (a), the Secretary shall develop a strategy to address gaps in research and gaps, overlap, and duplication among Federal programs, including those identified in findings made by reports of the Government Accountability Office. Such strategy shall address— ####
(1)gaps in research, including with respect to— #####
(A)the most appropriate treatment of pregnant women with opioid use disorders; #####
(B)the most appropriate treatment and management of infants with neonatal abstinence syndrome; and #####
(C)the long-term effects of prenatal opioid exposure on children; ####
(2)gaps, overlap, or duplication in— #####
(A)substance use disorder treatment programs for pregnant and postpartum women; and #####
(B)treatment program options for newborns with neonatal abstinence syndrome; ####
(3)gaps, overlap, or duplication in Federal efforts related to education about, and prevention of, neonatal abstinence syndrome; and ####
(4)coordination of Federal efforts to address neonatal abstinence syndrome. ###
(c)Report Not later than 1 year after the date of enactment of this Act, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report concerning the findings of the review conducted under subsection
(a)and the strategy developed under subsection (b).